Surgical Strategies for Pre- and Minimally Invasive Lung Adenocarcinoma 3.0: Lessons Learned From the Optimal Timing of Surgical Intervention

Yang Zhang; Zongwei Chen; Hong Hu; Haiquan Chen

doi:10.1053/j.semtcvs.2020.12.009

Surgical Strategies for Pre- and Minimally Invasive Lung Adenocarcinoma 3.0: Lessons Learned From the Optimal Timing of Surgical Intervention

Semin Thorac Cardiovasc Surg. 2022 Spring;34(1):311-314. doi: 10.1053/j.semtcvs.2020.12.009. Epub 2021 Jan 12.

Authors

Yang Zhang¹, Zongwei Chen², Hong Hu¹, Haiquan Chen³

Affiliations

¹ Departments of Thoracic Surgery and State Key Laboratory of Genetic Engineering, Fudan University Shanghai Cancer Center, Shanghai, China; Institute of Thoracic Oncology, Fudan University, Shanghai, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
² Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
³ Departments of Thoracic Surgery and State Key Laboratory of Genetic Engineering, Fudan University Shanghai Cancer Center, Shanghai, China; Institute of Thoracic Oncology, Fudan University, Shanghai, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China. Electronic address: [email protected].

PMID: 33444769
DOI: 10.1053/j.semtcvs.2020.12.009

Abstract

We discuss the optimal timing of surgery for lung cancer, and propose 3 surgical strategies for pre- and minimally invasive lung adenocarcinoma to avoid "overdiagnosis" and "overtreatment." Benign disease should not be treated as malignancy, pre- and minimally invasive disease should not be treated as invasive disease, and indolent malignancy should not be treated as aggressive malignancy.

Keywords: Preinvasive lung adenocarcinoma; Surgical strategies.

Publication types

Review

MeSH terms

Adenocarcinoma of Lung* / surgery
Adenocarcinoma* / surgery
Humans
Lung Neoplasms* / diagnostic imaging
Lung Neoplasms* / pathology
Lung Neoplasms* / surgery
Minimally Invasive Surgical Procedures
Treatment Outcome